Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Michelson Prizes: Next Generation Grants

The Michelson Medical Research Foundation

Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.

The Michelson Medical Research Foundation seeks to unravel the complexity of the human immune system, accelerating the development of vaccines and therapies for some of the world’s most threatening diseases.

The Michelson Prizes is looking for research proposals on human immunology and vaccine research. The committee will look for research that aims to tackle the current roadblocks to human vaccine development and expand our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development.

While the Michelson Prizes are focused on research in the fields of immunology, vaccine, and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply.

Application Criteria Details

$150,000 / 1-year grants to support research

Judged on innovation and potential impact

Research proposals must be on the topic of human immunology and vaccine development

Researchers 35 years of age and under are eligible

The 2026 Next Generation Grants will be accepting applications from April 1, 2025 - June 22, 2025

Download the full overview of the Michelson Prizes: Next Generation Grants

Key Dates

• Application portal opens: April 1, 2025

• Applications due: June 22, 2025, 11:59 pm EDT (UTC -4)

• Short-listed applicants notified: Sept. 1, 2025

• Supplementary information due: October 2025 (exact date to be communicated)

• Notice of award: December 2025

• Grant cycle: January 1 -- December 31, 2026

Specialties

Immunology

Eligibility Requirements

The Michelson Prizes is looking for research proposals on human immunology and vaccine research.

Sponsor Details

Sponsor Institute/Organizations: The Michelson Medical Research Foundation

Sponsor Type: Corporate

Address: 11755 Wilshire Boulevard, Suite 1400 Los Angeles, CA 90025

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity